Ceftazidime MIP

Medicinal product

(Invented) name

Ceftazidime MIP

Active substance (s)

Ceftazidimas

Strength

2 g

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DD02, Ceftazidime

Marketing authorisation holder

MIP Pharma GmbH, Vokietija

Date of authorisation

2015-05-13

Date of renewal

2020-12-22

Documents

3720 Pakuotės lapelis 2024 12 12.docx

3720 Ceftazidime MIP PCS PL 2024 12 12.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NO/H/0243/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Ceftazidimas	2 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
56462	70562	1070562	flakonas	N1		Receptinis	LT/1/15/3720/004	Netiekiama	-	-	No	-	-
62056	76429	1076429	flakonas	N5		Receptinis	LT/1/15/3720/005	Netiekiama	-	-	No	-	-
62057	76430	1076430	flakonas	N10		Receptinis	LT/1/15/3720/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-22	Perregistruotas
2015-05-13	Registruotas